Cargando…

P02-021 - Atypical CAPS consequence of novel NLPR3 mutations

Detalles Bibliográficos
Autores principales:	Gonzalez-Roca, E, Espinosa, G, Bartra, J, Ruiz-Ortiz, E, Rius, J, Plaza, S, Yague, J, Arostegui, JI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953046/ http://dx.doi.org/10.1186/1546-0096-11-S1-A128

Ejemplares similares

P02-002 - IL36RN mutations in patients with DITRA
por: Arostegui, JI, et al.
Publicado: (2013)

PW02-024-B - First report of AA amyloidosis in Blau syndrome
por: Ruiz-Ortiz, E, et al.
Publicado: (2013)

PW02-021 - SAA1 is the strongest predictor of AA in TRAPS
por: Obici, L, et al.
Publicado: (2013)

P02-022 - Atypical cryopirin associated periodic syndrome
por: Rivas, S Bujan, et al.
Publicado: (2013)

Atypical manifestations in CAPS sydrome: not so unfrequent?
por: Buján-Rivas, S, et al.
Publicado: (2015)

P02-029 - CAPS or SJIA
por: Alekseeva, E, et al.
Publicado: (2013)

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

PW02-031 - Genetic and clinical manifestations of CAPS
por: Bybee, AK, et al.
Publicado: (2013)

Development of a workflow to analyze autoinflammatory-associated genes using AccessArray™ system and next generation sequencing
por: Gonzalez-Roca, E, et al.
Publicado: (2015)

P02-014 - Consequences of Arginine 92 mutations in TNFR1
por: Jéru, I, et al.
Publicado: (2013)

P02-032 - CAPS: a novel mutation and an unusual phenotype
por: Insalaco, A, et al.
Publicado: (2013)

PW02-033 - Cytokine profile in CSF in CAPS patients
por: Schuh, E, et al.
Publicado: (2013)

PW02-037 - The Eurofever cohort of 136 patients with CAPS
por: Levy, R, et al.
Publicado: (2013)

PW02-027 - CAPS and cost-effectiveness analysis project
por: Alberighi, O Della Casa, et al.
Publicado: (2013)

NLPR3 Inflammasomes and Their Significance for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

P03-021 - Characterization of BM-MSC from osteopetrotic mice
por: Schena, F, et al.
Publicado: (2013)

PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
por: Stoffels, M, et al.
Publicado: (2013)

P01-021 – Macrophage migration inhibitory factory in FMF
por: Sari, I, et al.
Publicado: (2013)

Association between NLPR1, NLPR3, and P2X7R Gene Polymorphisms with Partial Seizures
por: Wang, Haidong, et al.
Publicado: (2017)

Somatic NLRP3 mosaicism in Muckle-Wells syndrome
por: Gonzalez-Roca, E, et al.
Publicado: (2015)

P02-027 - Quality of life in CAPS treated by Canakinumab
por: Marsaud, C, et al.
Publicado: (2013)

P02-033 - CAPS diagnosis and treatment in an Israeli family
por: Shinar, Y, et al.
Publicado: (2013)

PW02-026 - Low frequency variants of NLRP3 in CAPS patients
por: Lesche, M, et al.
Publicado: (2013)

PW01-021 – The phenotype of FMF due to deletion M694
por: Lachmann, HJ, et al.
Publicado: (2013)

PW02-028 - Association of novel NLRP3 mutations with CAPS phenotype in Turkish patients
por: Berdeli, A, et al.
Publicado: (2013)

PW02-025 - Programme necrosis by CAPS-associated NLRP3
por: Satoh, T, et al.
Publicado: (2013)

The NLPR3 inflammasome and obesity‐related kidney disease
por: Ke, Ben, et al.
Publicado: (2017)

The Role of Inflammasome NLPR3 in the Development and Therapy of Periodontitis
por: Zhao, Ying, et al.
Publicado: (2022)

P02-020 - CAPS in Turkish children: treatment with ANTI IL1
por: Eroglu, FK Kara, et al.
Publicado: (2013)

PW02-039 - Long-term anakinra treatment in CAPS: a metaanalys
por: Leinonen, M, et al.
Publicado: (2013)

P02-023 - NLRP3 mosaicism as a cause of late-onset CAPS
por: Zhou, Q, et al.
Publicado: (2013)

Significance of I313V mutation of NLPR3 gene in two pediatric patients
por: Omenetti, A, et al.
Publicado: (2011)

Beamline P02.1 at PETRA III for high-resolution and high-energy powder diffraction
por: Dippel, Ann-Christin, et al.
Publicado: (2015)

Description of a case of late-onset cryopyrin-associated periodic syndrome due to low-level somatic NLRP3 mosaicism
por: Mensa-Vilaro, A, et al.
Publicado: (2015)

P02-026 - Model-based characterization of the PKPD relationship for canakinumab in CAPS: a step towards personalized
por: Gautier, A, et al.
Publicado: (2013)

PW02-018 - Impact of PSTPIP1 mutaions on clinical phenotype
por: Holzinger, D, et al.
Publicado: (2013)

PW02-007 - The Eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

LBODP021 Multifactorial Hypercalcemia
por: Ramachandran, Aishwarya, et al.
Publicado: (2022)

Expression of NLPR3 in Psoriasis Is Associated with Enhancement of Interleukin-1β and Caspase-1
por: Su, Fei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_verar44qdtg1pjf0rpt6j5s5pp